Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.

[1]  R. Kormos,et al.  Outcomes of the First 1300 Adult Heart Transplants in the United States After the Allocation Policy Change. , 2020, Circulation.

[2]  Pavel S. Roshanov,et al.  Use of GRADE for assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. , 2020, Journal of clinical epidemiology.

[3]  S. Restaino,et al.  Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction , 2020, Clinical transplantation.

[4]  C. Hayward,et al.  Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation , 2019, Transplantation.

[5]  M. Pasque,et al.  Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor , 2019, Clinical transplantation.

[6]  G. Couper,et al.  A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation , 2019, Journal of Artificial Organs.

[7]  J. Mehaffey,et al.  Primary graft dysfunction after heart transplantation: Outcomes and resource utilization , 2019, Journal of cardiac surgery.

[8]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  P. Leprince,et al.  Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk. , 2019, Transplantation.

[10]  D. Freimark,et al.  Does donor‐recipient age difference matter in outcome of heart transplantation? , 2019, Clinical transplantation.

[11]  G. Gonzalez-Stawinski,et al.  Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant , 2019, Clinical transplantation.

[12]  G. Guyatt,et al.  Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  N. Al-Attar,et al.  ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study , 2019, Transplantation.

[14]  Y. Naka,et al.  Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  M. Antunes,et al.  Primary graft failure after cardiac transplantation: prevalence, prognosis and risk factors. , 2018, Interactive cardiovascular and thoracic surgery.

[16]  X. Armoiry,et al.  Extracorporeal life support for primary graft dysfunction after heart transplantation. , 2018, Interactive cardiovascular and thoracic surgery.

[17]  D. Freimark,et al.  Donor‐recipient ethnic mismatching impacts short‐ and long‐term results of heart transplantation , 2018, Clinical transplantation.

[18]  J. Felius,et al.  Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation. , 2018, Interactive cardiovascular and thoracic surgery.

[19]  M. Beňa,et al.  Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant. , 2018, Interactive cardiovascular and thoracic surgery.

[20]  J. Felius,et al.  Donor predicted heart mass as predictor of primary graft dysfunction. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  M. Swaminathan,et al.  Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  A. Ardehali,et al.  Primary graft dysfunction in heart transplantation , 2018, Current opinion in organ transplantation.

[23]  A. Pavie,et al.  Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysis. , 2018, Clinics and research in hepatology and gastroenterology.

[24]  L. Potena,et al.  Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  A. Ducharme,et al.  EARLY CIRCULATORY SUPPORT WITH EXTRACORPOREAL MEMBRANE OXYGENATION IMPROVES OUTCOMES AFTER SEVERE GRAFT DYSFUNCTION , 2017 .

[26]  B. Levin,et al.  Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  Y. Sakata,et al.  Factors Related to the Severity of Early Postoperative Infection After Heart Transplantation in Patients Surviving Prolonged Mechanical Support Periods: Experience at a Single University. , 2017, Journal of cardiothoracic and vascular anesthesia.

[28]  C. Chabanne,et al.  Impact of donor comorbidities on heart transplant outcomes in the modern era. , 2017, Interactive cardiovascular and thoracic surgery.

[29]  M. Farr,et al.  Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  T. Kohmoto,et al.  To use or not to use? Amiodarone before heart transplantation , 2017, Surgery.

[31]  D. Dunkler,et al.  Acute Kidney Injury and Outcome After Heart Transplantation: Large Differences in Performance of Scoring Systems , 2016, Transplantation.

[32]  E. Roig,et al.  Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation. , 2016, Transplantation proceedings.

[33]  J. Squiers,et al.  Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre† , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  P. Loyalka,et al.  Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation: A Single-center Experience. , 2016, Transplantation proceedings.

[35]  J. Pirk,et al.  Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction. , 2016, Physiological research.

[36]  H. Ishibashi-Ueda,et al.  Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan , 2016, Heart and Vessels.

[37]  M. Kuchibhatla,et al.  Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction. , 2016, Journal of cardiac failure.

[38]  F. Atik,et al.  Experience of ECMO in Primary Graft Dysfunction after Orthotopic Heart Transplantation , 2015, Arquivos brasileiros de cardiologia.

[39]  G. Guyatt,et al.  Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients , 2015, BMJ : British Medical Journal.

[40]  J. Pirk,et al.  Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support. , 2015, Interactive cardiovascular and thoracic surgery.

[41]  M. Aerts,et al.  Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.

[42]  M. Pilato,et al.  Extracorporeal Membrane Oxygenation for Graft Failure after Heart Transplantation: A Multidisciplinary Approach to Maximize Weaning Rate , 2014, The International journal of artificial organs.

[43]  S. Russell,et al.  Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  C. Bombardier,et al.  Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.

[45]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[46]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[47]  J. Barceló,et al.  RADIAL: a novel primary graft failure risk score in heart transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[48]  G. Guyatt,et al.  Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest. , 2019, Journal of clinical epidemiology.